RCUS
Arcus Biosciences Inc
24.40$
-3.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 57.8 | 39.2 | 27.4 | 23.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 54.9 | 132.6 | 74.1 | 55.8 | 61.4 | 37.5 | 58.7 | 29.7 | 41.0 | 80.0 | 14.3 | 21.3 | 22.1 | 20.6 | 64.6 | 8.0 | 5.7 | 4.4 | 4.4 | 13.5 | 11.2 | 12.3 | 11.2 | 12.2 | 6.9 | 5.6 | 5.3 | 5.3 | 5.5 | 3.3 | 6.0 | 10.3 | 11.5 | 33.2 | |
| – | – | – | – | – | 0.5 | 2.0 | 2.4 | 2.0 | 2.5 | 1.8 | 2.3 | 2.7 | 4.4 | 2.8 | 2.0 | 3.3 | 2.8 | 3.2 | 4.5 | 3.6 | 2.8 | 2.4 | 2.7 | 2.3 | 2.2 | 2.6 | 2.6 | 3.1 | 2.3 | 2.2 | 2.5 | 2.8 | 1.5 | 1.6 | 3.3 | 4.1 | 5.2 | 8.4 | |
| – | – | – | – | – | -18.2 | 90.3 | 65.6 | 48.0 | 54.6 | 31.0 | 48.5 | 26.4 | 37.2 | 62.2 | 11.9 | 19.1 | 17.9 | 17.6 | 61.3 | 7.6 | – | – | – | 11.6 | – | 10.9 | 9.8 | 11.3 | 6.1 | 5.0 | 4.8 | 4.9 | 4.6 | 2.8 | 5.5 | 9.9 | 11.1 | 32.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 48.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.4 | 15.3 | 27.1 | 139.3 | – | – | 5.1 | 4.1 | 4.4 | 3.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -22.7% | -7.0% | -4.0% | -10.0% | -9.2% | -16.6% | -18.3% | -16.9% | -14.5% | -7.8% | 13.5% | 6.5% | 3.7% | 0.7% | -10.8% | -9.2% | 19.5% | 24.6% | 22.5% | 28.3% | -24.5% | -21.3% | -22.8% | -23.0% | -14.4% | -19.3% | -12.1% | -12.9% | -39.0% | -39.6% | -32.0% | -18.9% | -18.1% | -12.2% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -17,007.4% | -865.2% | -194.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.2% | 98.0% | 97.0% | 94.0% | |
| – | – | – | -35,754.6% | -3,782.2% | -2,233.3% | -1,679.2% | -680.5% | -656.8% | -681.1% | -786.5% | -1,242.9% | -591.4% | -655.6% | -763.7% | -115.4% | -160.3% | -197.8% | -214.5% | -736.8% | 14.2% | 15.3% | 16.4% | 17.4% | -251.2% | -252.4% | -259.8% | -270.3% | -290.6% | -113.9% | -118.6% | -120.9% | -127.9% | -309.2% | -129.0% | -156.3% | -156.3% | -168.6% | -415.4% | |
| – | – | – | -35,485.9% | -3,756.7% | -2,209.4% | -1,605.4% | -628.1% | -593.7% | -613.5% | -736.3% | -1,180.4% | -564.7% | -632.0% | -745.2% | -112.6% | -158.5% | -196.8% | -213.7% | -735.1% | 13.8% | 14.7% | 16.2% | 18.4% | -239.5% | -235.5% | -238.2% | -245.3% | -262.4% | -97.5% | -100.8% | -102.7% | -109.7% | -277.3% | -116.8% | -145.4% | -142.9% | -156.4% | -386.3% | |
| – | – | – | – | -2,163.7% | -1,244.4% | -926.7% | -299.5% | -559.5% | -563.7% | -620.4% | -1,072.9% | -502.6% | -596.0% | -622.0% | 192.7% | 139.5% | 81.7% | 14.8% | -694.6% | -73.7% | 112.1% | 109.2% | 98.4% | 381.4% | -274.8% | -262.0% | -255.8% | -282.1% | -99.2% | -108.1% | -64.3% | -68.2% | -214.9% | -130.5% | -193.3% | -196.0% | -207.2% | -406.0% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -34.5% | -22.1% | -24.7% | -20.6% | -21.1% | -24.5% | -35.0% | -45.4% | -51.7% | -67.4% | -26.1% | -16.1% | -24.5% | -25.2% | -32.8% | -51.3% | 6.3% | 7.2% | 8.9% | 11.4% | -40.7% | -46.6% | -50.8% | -56.4% | -66.5% | -32.7% | -39.2% | -47.8% | -58.4% | -73.6% | -55.7% | -80.0% | -55.9% | -70.4% | -97.4% | |
| – | – | – | – | -27.9% | -19.3% | -21.4% | -17.6% | -18.0% | -21.0% | -28.8% | -37.1% | -41.7% | -53.8% | -23.2% | -10.8% | -15.9% | -17.9% | -22.1% | -33.2% | 3.3% | 3.7% | 4.5% | 5.7% | -19.9% | -22.3% | -23.6% | -24.6% | -28.0% | -17.9% | -21.0% | -21.6% | -24.6% | -33.8% | -28.5% | -35.8% | -31.0% | -37.0% | -48.9% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -95 | -195 | -166 | -68 | -65 | -61 | -61 | -69 | -48 | -57 | -266 | -186 | -171 | -360 | -282 | -124 | -143 | – | – | – | -203 | – | -173 | -175 | -116 | -174 | -145 | -143 | -90 | -132 | -139 | -127 | -110 | -88 | -36 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 90.7% | – | – | – | 80.8% | 87.3% | 86.6% | 85.5% | 85.5% | 85.7% | 82.3% | 81.7% | 80.7% | 79.8% | 89.1% | 67.1% | 65.0% | 71.1% | 67.3% | 64.7% | 52.9% | 51.6% | 50.6% | 50.1% | 48.8% | 47.8% | 46.4% | 43.7% | 42.2% | 54.7% | 53.5% | 45.1% | 42.2% | 45.9% | 51.1% | 44.8% | 55.4% | 52.6% | 50.2% | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | – | – | – | 0.0 | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -2.36 | -2.16 | -6.20 | -1.48 | -1.18 | -1.15 | -1.25 | -1.57 | -1.83 | -1.92 | -2.14 | -2.30 | -1.34 | -1.93 | -2.50 | -2.85 | -3.97 | 0.70 | 0.81 | 0.92 | 1.10 | -3.68 | -3.83 | -3.93 | -3.93 | -4.09 | -2.68 | -2.73 | -2.95 | -3.09 | -3.97 | -2.87 | -3.28 | -3.29 | -2.94 | -3.58 | |
| – | – | – | 0.01 | 0.06 | 0.28 | 0.09 | 0.19 | 0.19 | 0.20 | 0.21 | 0.16 | 0.34 | 0.34 | 0.31 | 1.19 | 1.22 | 1.27 | 1.33 | 0.54 | 5.08 | 5.50 | 5.69 | 5.99 | 1.54 | 1.63 | 1.65 | 1.60 | 1.56 | 2.75 | 2.71 | 2.88 | 2.81 | 1.43 | 2.46 | 2.25 | 2.30 | 1.88 | 0.93 | |
| – | 4.05 | – | – | 6.27 | 28.10 | 5.99 | 5.72 | 5.44 | 5.09 | 4.49 | 4.03 | 3.72 | 3.18 | 8.83 | 8.36 | 7.91 | 9.91 | 8.67 | 7.74 | 11.17 | 11.19 | 10.41 | 9.67 | 9.05 | 8.22 | 7.73 | 6.97 | 6.16 | 8.20 | 6.97 | 6.18 | 5.29 | 5.40 | 5.15 | 4.09 | 5.88 | 4.18 | 3.68 | |
| – | – | – | – | -1.25 | -3.49 | -0.85 | -0.56 | -1.08 | -1.15 | -1.32 | -1.66 | -1.71 | -2.02 | -1.92 | 2.30 | 1.70 | 1.04 | 0.20 | -3.75 | -3.75 | 6.16 | 6.22 | 5.89 | 5.87 | -4.47 | -4.32 | -4.10 | -4.40 | -2.73 | -2.93 | -1.85 | -1.92 | -3.08 | -3.21 | -4.36 | -4.51 | -3.90 | -3.77 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.